Equity Field Notes from temporal sources

[DanWebzster]

VKTX (update)

MDGL is now valued at 6x VKTX. If the H2 Ph2 NAFELD read out goes well VKTX should undergo another upward re-valuation.

In addition, VK5211 demonstrated promising signs of efficacy in a mid-stage trial in patients who recently suffered a hip fracture.

VKTX is seeking a partnership for VKTX

VKTX raised gross proceeds of $67.5mn in 6/18.